The state of macrophage differentiation determines the TNFα response to nitrated lipoprotein uptake

Atherosclerosis

Volumn 170, Issue 2, 2003, Pages 213-221

  Smythe, Cheryl D W ^a   Skinner, Vernon O ^b   Bruckdorfer, K Richard ^b   Haskard, Dorian O ^a   Landis, R Clive ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Differentiation; Inflammation; LDL; Macrophage; TNF

Indexed keywords

LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; NITRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

EID: 0242409639     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00285-5     Document Type: Article

References (47)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340:(2):1999;115-126.
2. Lessner S.M., Prado H.L., Waller E.K., Galis Z.S. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 160:(6):2002;2145-2155.
3. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:(2):1998;275-281.
4. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:(6696):1998;894-897.
5. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:(1):1999;205-211.
6. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest. 102:(1):1998;145-152.
7. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med. 191:(1):2000;189-194.
8. Bourdillon M.C., Poston R.N., Covacho C., Chignier E., Bricca G., McGregor J.L. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE (-/-)/ICAM-1(-/-) fed a fat or a chow diet. Arterioscler. Thromb. Vasc. Biol. 20:(12):2000;2630-2635.
9. Cybulsky M.I., Iiyama K., Li H., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:(10):2001;1255-1262.
10. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA. 92:(18):1995;8264-8268.
11. Newman S.L., Henson J.E., Henson P.M. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156:(2):1982;430-442.
12. Meagher L.C., Savill J.S., Baker A., Fuller R.W., Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. Leukoc. Biol. 52:(3):1992;269-273.
13. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:1999;593-623.
14. Uchimura E., Kodaira T., Kurosaka K., Yang D., Watanabe N., Kobayashi Y. Interaction of phagocytes with apoptotic cells leads to production of pro-inflammatory cytokines. Biochem. Biophys. Res. Commun. 239:(3):1997;799-803.
15. Yagnik D.R., Hillyer P., Marshall D., Smythe C.D., Krausz T., Haskard D.O., Landis R.C. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum. 43:(8):2000;1779-1789.
16. Landis R.C., Yagnik D.Y., Florey O., Philippidis P., Emons V., Mason J.C., Haskard D.O. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 46:(11):2002;3026-3033.
17. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers the capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181:(5):1995;1857-1862.
18. Fadok V.A., Warner M.L., Bratton D.L., Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161:(11):1998;6250-6257.
19. Sambrano G.R., Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA. 92:(5):1995;1396-1400.
20. Bird D.A., Gillotte K.L., Horkko S., Friedman P., Dennis E.A., Witztum J.L., Steinberg D. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. USA. 96:(11):1999;6347- 6352.
21. Chang M.K., Bergmark C., Laurila A., et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96:(11):1999;6353-6358.
22. Podrez E.A., Febbraio M., Sheibani N., et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105:(8):2000;1095-1108.
23. Chung B.H., Wilkinson T., Geer J.C., Segrest J.P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21:(3):1980;284-291.
24. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:(1):1978;206-210.
25. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:(4):1990;1620-1624.
26. Ettelaie C., Wilbourn B.R., Adam J.M., Bruckdorfer K.R. Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation. Arterioscler. Thromb. Vasc. Biol. 19:(7):1999;1784-1790.
27. Leenen P.J., Jansen A.M., Van Ewijk W. Murine macrophage cell lines can be ordered in a linear differentiation sequence. Differentiation. 32:(2):1986;157-164.
28. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:(1):1994;437-444.
29. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:(3):1997;1433-1436.
30. Podrez E.A., Poliakov E., Shen Z., et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277:(41):2002;38517-38523.
31. Podrez E.A., Poliakov E., Shen Z., et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277:(41):2002;38503-38516.
32. Ku G., Thomas C.E., Akeson A.L., Jackson R.L. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:(20):1992;14183-14188.
33. Jovinge S., Ares M.P., Kallin B., Nilsson J. Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler. Thromb. Vasc. Biol. 16:(12):1996;1573-1579.
34. Li S.R., Forster L.A., Anggard E.E., Ferns G.A. RT-PCR study on the effects of minimally modified low-density lipoproteins and probucol treatment on gene expressions of interleukin-1 and platelet-derived growth factor B-chain in human peripheral blood mononuclear cells. Biol. Signals. 5:(5):1996;263-274.
35. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14:(1):1994;47-53.
36. Hamilton T.A., Ma G.P., Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:(6):1990;2343-2350.
37. Fong L.G., Fong T.A., Cooper A.D. Inhibition of lipopolysaccharide- induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid Res. 32:(12):1991;1899-1910.
38. Thai S.F., Lewis J.G., Williams R.B., Johnson S.P., Adams D.O. Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells. J. Leukoc. Biol. 57:(3):1995;427-433.
39. Ohlsson B.G., Englund M.C., Karlsson A.L., et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J. Clin. Invest. 98:(1):1996;78-89.
40. Englund M.C., Karlsson A.L., Wiklund O., Bondjers G., Ohlsson B.G. 25-Hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-alpha secretion in macrophages. Atherosclerosis. 58:(1):2001;61-71.
41. Ishibashi S., Inaba T., Shimano H., et al. Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J. Biol. Chem. 265:(24):1990;14109-14117.
42. Geng Y.J., Hansson G.K. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89:(4):1992;1322-1330.
43. van der Kooij M.A., Morand O.H., Kempen H.J., van Berkel T.J. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 16:(1):1996;106-114.
44. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93:(2):1998;229-240.
45. Chung S.W., Kang B.Y., Kim S.H., Pak Y.K., Cho D., Trinchieri G., Kim T.S. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J. Biol. Chem. 275:(42):2000;32681-32687.
46. Guy R.A., Maguire G.F., Crandall I., Connelly P.W., Kain K.C. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. Atherosclerosis. 155:(1):2001;19-28.
47. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:(4):1998;890-898.